The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: An analysis of the National Cancer Data Base.

Palm, Russell F; Oliver, Daniel E; Yang, George Q; Abuodeh, Yazan; Naghavi, Arash O; Johnstone, Peter A S

Palm, Russell F; Oliver, Daniel E; Yang, George Q; Abuodeh, Yazan; Naghavi, Arash O; Johnstone, Peter A S.

Affiliation

Palm RF; Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Oliver DE; Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Yang GQ; Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Abuodeh Y; Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Naghavi AO; Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Johnstone PAS; Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

Cancer ; 125(4): 642-651, 2019 02 15.

Article de En | MEDLINE | ID: mdl-30644538

Sujet(s)
Mots clés

chondrosarcoma; chordoma; dose escalation; proton therapy; survival

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs osseuses / Chordome / Chondrosarcome / Protonthérapie Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Cancer Année: 2019 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google